Related Experiment Videos
Camelid heavy-chain variable domains provide efficient combining sites to haptens
S Spinelli1, L G Frenken, P Hermans
1Architecture et Fonction des Macromolecules Biologiques, CNRS, UPR-9039, 31 Chemiin Joseph Aiguier, 13402 Marseille Cedex 20, France.
Biochemistry
|February 24, 2000
Summary
Camelid heavy-chain variable domains (VHH) can bind small molecules like haptens. This study determined the structure of a VHH fragment complexed with a Reactive Red hapten, showing their potential in biotechnology.
Area of Science:
- Biochemistry
- Structural Biology
- Immunology
Background:
- Camelids produce unique antibodies lacking light chains and CH1 domains.
- Camelid heavy-chain variable domains (VHH) exhibit high affinity for protein antigens.
- The capacity of small, monomeric VHH fragments to bind haptens remained uncertain.
Purpose of the Study:
- To investigate the ability of VHH fragments to bind haptens.
- To determine the structural basis for VHH-hapten interaction.
- To explore the biotechnological applications of VHH fragments in hapten binding.
Main Methods:
- Generation of llama antibodies against the azo-dye hapten Reactive Red (RR6).
- Determination of the crystal structure of a VHH fragment complexed with a dimeric RR6 hapten.
- Measurement of the dissociation constant for the VHH-hapten interaction.
Main Results:
- Successfully raised llama antibodies against RR6.
- Determined the crystal structure of the VHH-RR6 complex, revealing a large interaction surface (approx. 300 A²).
- Measured a low dissociation constant (22 nM) for the VHH-monomer interaction, indicating high affinity.
- Identified specific interactions, including histidine residues in CDR1 binding to copper atoms of the hapten.
Conclusions:
- VHH fragments possess an efficient combining site for haptens, utilizing their CDR loops.
- VHH fragments demonstrate significant potential for selecting, removing, or capturing haptens.
- These findings suggest VHH fragments have broad biotechnological applications beyond protein recognition.